Contraceptive prevalence, any modern method in Belarus
Belarus: Contraceptive prevalence, any modern method was 45.9% in 2019. ▲ Rising
Contraceptive prevalence, any modern method in Belarus, 1995–2019
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Belarus is 45.9%, measured in 2019.
That represents a change of down 22.6% on the previous year and down 11.6% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Belarus peaked at 59.3% in 2017 and was at its lowest, 42.1%, in 1995.
That places Belarus 59th out of 113 countries with data for 2019, putting it in the middle of the range.
Contraceptive prevalence, any modern method in Belarus, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1995 | 42.1% | — |
| 2005 | 57.0% | +35.5% |
| 2012 | 51.9% | -8.9% |
| 2017 | 59.3% | +14.1% |
| 2019 | 45.9% | -22.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 42.1% | 42.1% | 42.1% | 1 |
| 2000s | 57.0% | 57.0% | 57.0% | 1 |
| 2010s | 52.4% | 45.9% | 59.3% | 3 |
Countries ranked near Belarus
More health data for Belarus
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,674 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Population ages 15-19, male, annual growth rate 4.5 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.029 units per person (2025)
- Population ages 20-24, female, annual growth rate -0.5812 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0231 units per person (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Belarus?
- Contraceptive prevalence, any modern method in Belarus was 45.9% in 2019, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Belarus?
- The highest recorded value was 59.3% in 2017.
- What is the lowest contraceptive prevalence, any modern method recorded in Belarus?
- The lowest recorded value was 42.1% in 1995.
- How does Belarus rank for contraceptive prevalence, any modern method?
- Belarus ranks 59th out of 113 countries with data for 2019.
- Is contraceptive prevalence, any modern method rising or falling in Belarus?
- Over the last ten years it is down 11.6%. The long-run trend across the full record is rising.
- Where does this Belarus data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.